Antiangiogenic antineoplastic combined chemotherapy protocols. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy14

Cell Line, Tumor Endothelial Cells Tumor Cells, Cultured Chorioallantoic Membrane Endothelium, Vascular Human Umbilical Vein Endothelial Cells Cells, Cultured Umbilical Veins Allantois Cell Line Chorion Pericytes HT29 Cells Chick Embryo

Organisms6

Mice, Nude Mice, SCID Mice, Inbred BALB C Mice, Inbred C57BL Narcissus Aster Plant

Diseases55

Osteosarcoma Precursor Cell Lymphoblastic Leukemia-Lymphoma Neovascularization, Pathologic Neoplasms Breast Neoplasms Lung Neoplasms Brain Neoplasms Neoplasm Metastasis Ovarian Neoplasms Neoplasm Recurrence, Local Adenocarcinoma Neoplasms, Experimental Carcinoma, Non-Small-Cell Lung Colorectal Neoplasms Corneal Neovascularization Colonic Neoplasms Liver Neoplasms Glioblastoma Glioma Melanoma, Experimental Vomiting Carcinoma, Lewis Lung Nausea Disease Progression Lymphoma, Non-Hodgkin Bone Neoplasms Neutropenia Carcinoma Carcinoma, Squamous Cell Disease Models, Animal Testicular Neoplasms Pancreatic Neoplasms Kidney Neoplasms Leukopenia Prostatic Neoplasms Leukemia P388 Hodgkin Disease Lymphoma Neoplasms, Germ Cell and Embryonal Head and Neck Neoplasms Mammary Neoplasms, Experimental Retinal Neovascularization Carcinoma, Renal Cell Lymphatic Metastasis Multiple Myeloma Recurrence Stomach Neoplasms Leukemia, Myeloid, Acute Peritoneal Neoplasms Thrombocytopenia Melanoma Leukemia L1210 Sarcoma Germinoma Leukemia

Chemicals and Drugs99

Antineoplastic Agents Angiogenesis Inhibitors Doxorubicin Cyclophosphamide Cisplatin Vincristine Endostatins Antineoplastic Agents, Phytogenic Vascular Endothelial Growth Factor A Antibiotics, Antineoplastic Paclitaxel Antineoplastic Agents, Alkylating Etoposide Angiostatins Thrombospondin 1 Antimetabolites, Antineoplastic Methotrexate Antibodies, Monoclonal, Humanized Vascular Endothelial Growth Factor Receptor-2 Taxoids Vinblastine Pyrroles Deoxycytidine Carboplatin Bleomycin Receptors, Vascular Endothelial Growth Factor Cyclohexanes Ifosfamide Cytarabine Antibodies, Monoclonal Organoplatinum Compounds Vascular Endothelial Growth Factor Receptor-1 Anthracyclines Camptothecin Indoles Daunorubicin Sesquiterpenes Carmustine Dacarbazine Angiogenic Proteins Thalidomide Tumor Markers, Biological Drug Combinations Lomustine Mitomycin Serpins Fibroblast Growth Factor 2 Bibenzyls Endothelial Growth Factors Melphalan Vascular Endothelial Growth Factors Bridged Compounds Protein Kinase Inhibitors Recombinant Proteins Antigens, CD31 Mitoxantrone Phenylurea Compounds Integrin alphaVbeta3 6-Mercaptopurine Epothilones Hydroxyquinolines Gallium Lymphokines Niacinamide Enzyme Inhibitors Drugs, Investigational Prodrugs Bryostatins Ellipticines Phospholipid Ethers Granulocyte Colony-Stimulating Factor Floxuridine RNA, Messenger Topotecan Thiadiazines Platinum Compounds Benzenesulfonates Antiemetics Quinazolines Neoplasm Proteins Angiostatic Proteins Thiotepa Peptide Fragments Pyridines Razoxane Collagen Type XVIII Dexamethasone Tegafur Sulfonamides Amaryllidaceae Alkaloids Phthalazines P-Glycoprotein Angiogenesis Inducing Agents Radiation-Sensitizing Agents Tubulin Modulators Isocoumarins Mitomycins Plasminogen Laminin

Analytical, Diagnostic and Therapeutic Techniques and Equipment62

Antineoplastic Combined Chemotherapy Protocols Combined Modality Therapy Disease-Free Survival Treatment Outcome Chemotherapy, Adjuvant Prognosis Retrospective Studies Clinical Protocols Xenograft Model Antitumor Assays Drug Administration Schedule Neoadjuvant Therapy Survival Analysis Survival Rate Drug Screening Assays, Antitumor Neoplasm Staging Neoplasm Transplantation Clinical Trials as Topic Neoplasms, Experimental Induction Chemotherapy Follow-Up Studies Tumor Burden Immunohistochemistry Melanoma, Experimental Transplantation, Heterologous Administration, Metronomic Prospective Studies Chemotherapy, Cancer, Regional Perfusion Salvage Therapy Radiotherapy Drug Evaluation, Preclinical Disease Models, Animal Infusions, Intravenous Transplantation, Autologous Randomized Controlled Trials as Topic Genetic Therapy Administration, Oral Kaplan-Meier Estimate Radiotherapy, Adjuvant Drug Delivery Systems Blotting, Western Drug Evaluation Antineoplastic Protocols Reverse Transcriptase Polymerase Chain Reaction Inhibitory Concentration 50 Mammary Neoplasms, Experimental Clinical Trials, Phase III as Topic Infusions, Intra-Arterial Gloves, Protective Hematopoietic Stem Cell Transplantation Flow Cytometry Magnetic Resonance Imaging Radiotherapy Dosage Drug Therapy Palliative Care Feasibility Studies Clinical Trials, Phase II as Topic Molecular Targeted Therapy Predictive Value of Tests Models, Biological Risk Factors Injections, Intraperitoneal Tomography, X-Ray Computed

Phenomena and Processes18

Drug Resistance, Neoplasm Dose-Response Relationship, Drug Apoptosis Time Factors Cell Proliferation Neovascularization, Physiologic Drug Synergism Cell Division Cell Survival Cell Movement Gene Expression Regulation, Neoplastic Signal Transduction Cell Cycle Inhibitory Concentration 50 Cell Hypoxia Drug Resistance, Multiple Molecular Structure Cell Growth Processes

Disciplines and Occupations2

Immunohistochemistry Oncology Nursing

Technology, Industry, Agriculture1

Gloves, Protective

Information Science1

Health Care20

Disease-Free Survival Treatment Outcome Retrospective Studies Clinical Protocols Survival Analysis Survival Rate Clinical Trials as Topic Follow-Up Studies Prospective Studies Randomized Controlled Trials as Topic Kaplan-Meier Estimate Antineoplastic Protocols Clinical Trials, Phase III as Topic Oncology Nursing Palliative Care Feasibility Studies Clinical Trials, Phase II as Topic Occupational Exposure Predictive Value of Tests Risk Factors

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

Antineoplastic Combined Chemotherapy Protocols Antineoplastic Agents Angiogenesis Inhibitors Doxorubicin Cyclophosphamide Combined Modality Therapy Osteosarcoma Cisplatin Disease-Free Survival Vincristine Treatment Outcome Chemotherapy, Adjuvant Prognosis Precursor Cell Lymphoblastic Leukemia-Lymphoma Neovascularization, Pathologic Retrospective Studies Neoplasms Endostatins Clinical Protocols Antineoplastic Agents, Phytogenic Cell Line, Tumor Vascular Endothelial Growth Factor A Xenograft Model Antitumor Assays Antibiotics, Antineoplastic Breast Neoplasms Mice, Nude Lung Neoplasms Paclitaxel Antineoplastic Agents, Alkylating Etoposide Angiostatins Thrombospondin 1 Drug Administration Schedule Neoadjuvant Therapy Drug Resistance, Neoplasm Antimetabolites, Antineoplastic Dose-Response Relationship, Drug Survival Analysis Apoptosis Methotrexate Antibodies, Monoclonal, Humanized Survival Rate Drug Screening Assays, Antitumor Neoplasm Staging Endothelial Cells Time Factors Cell Proliferation Neoplasm Transplantation Brain Neoplasms Vascular Endothelial Growth Factor Receptor-2 Taxoids Vinblastine Tumor Cells, Cultured Neovascularization, Physiologic Pyrroles Neoplasm Metastasis Deoxycytidine Carboplatin Ovarian Neoplasms Bleomycin Drug Synergism Receptors, Vascular Endothelial Growth Factor Neoplasm Recurrence, Local Cyclohexanes Chorioallantoic Membrane Adenocarcinoma Cell Division Clinical Trials as Topic Ifosfamide Cytarabine Cell Survival Antibodies, Monoclonal Organoplatinum Compounds Neoplasms, Experimental Induction Chemotherapy Endothelium, Vascular Carcinoma, Non-Small-Cell Lung Vascular Endothelial Growth Factor Receptor-1 Anthracyclines Colorectal Neoplasms Mice, SCID Camptothecin Corneal Neovascularization Follow-Up Studies Tumor Burden Indoles Daunorubicin Sesquiterpenes Colonic Neoplasms Mice, Inbred BALB C Immunohistochemistry Carmustine Liver Neoplasms Dacarbazine Glioblastoma Glioma Angiogenic Proteins Melanoma, Experimental Thalidomide Vomiting

No FAQ available that match "antiangiogenic antineoplastic combined chemotherapy protocols"